Obesity accelerates the loss of COVID-19 vaccine-induced neutralizing antibody capacity, concludes a study of 3.6 million adults.
Severe obesity poses 76% higher risk of poor COVID-19 outcomes, study suggests
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Caregiver stress lessened after pandemic lockdowns lifted, study finds
- Dip in alcohol consumption in early pandemic linked to less social drinking
- High-risk patients with COVID symptoms should use PCR rather than rapid tests, study suggests
- Peer support valuable intervention for health worker stress during COVID-19, study shows